Cancer scientists say they have engineered a new type of super-strong antibody which could be used to boost the immune systems of patients fighting the disease. Experts from the University of ...
Researchers from David Baker's lab (University of Washington) have designed this antibody from scratch to neutralize a deadly toxin from C. difficile. [Ian Haydon] “Life could not exist without ...
The Asia-Pacific AI in antibody discovery market is anticipated to soar to $1.24 billion by 2035, up from $118.7 million in ...
Over decades, antibodies have established themselves as a key therapeutic modality for a wide range of diseases. But antibodies as they are found in nature did not evolve to be used as drugs, says ...
Artificial intelligence (AI) and "protein language" models can speed the design of monoclonal antibodies that prevent or reduce the severity of potentially life-threatening viral infections, according ...
The AI in Antibody Discovery Market is projected to grow from USD 529.9 million in 2025 to USD 4.84 billion by 2035, at a 24.76% CAGR. This growth is fueled by the inefficiencies of traditional ...
Antibodies are one of the most active areas of therapeutics development, with the global antibody market valued at $210 billion in 2022 and projected to reach almost half a trillion by 2030. These ...
G-protein coupled receptors (GPCRs) are the largest protein family encoded by the human genome and represent approximately one-third of all drug targets. However, most GPCR-targeting drugs are small ...
Cryogenic electron microscopy (cryo-EM) resolution of the structure of a respiratory syncytial virus fusion protein (shades of pink) bound to fragments of two antibodies (dark/light and blue/green) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results